Logo

Adaptive Biotechnologies

JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More

Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.

New Products Posted to GenomeWeb: Thermo Fisher, Adaptive Biotech, Qiagen, Dolomite Bio, More

New products and services posted to GenomeWeb for the week of Nov. 28, 2022.

Adaptive Bio Narrows 2022 Revenue Guidance, Outlines Financial Expectations

Releasing Q3 results, the Seattle-based immune system biotechnologies firm set its new full-year revenue guidance to the range of $185 million to $190 million.

Adaptive Biotechnologies Inks Partnership to Integrate MRD Assay With Epic's EMR System

After the expected integration in 2023, providers can order Adaptive’s ClonoSeq assay and review the results using the Epic electronic medical record system.

Adaptive Biotechnologies Inks Financing Deal Worth up to $250M

The Seattle-based biotech company will receive the money in exchange for a percentage of its GAAP revenues.

Aug 4, 2022

Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium

Jul 28, 2022

Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma

Jun 21, 2022

Adaptive Biotechnologies Looks to Refocus T-Cell Profiling Tech in Wake of Restructuring 
Premium

Jun 17, 2022

New Products Posted to GenomeWeb: Roche, Adaptive Biotech, GenTegra, More

May 5, 2022

Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses
Premium

May 4, 2022

Adaptive Biotechnologies Q1 Revenues Rise Slightly in Q1

Mar 11, 2022

People in the News: New Appointments at Adaptive Biotech, NeoGenomics, Biological Dynamics, More

Mar 9, 2022

Adaptive Biotechnologies Cuts Workforce as Part of Restructuring, Appoints New CFO

Mar 3, 2022

Adaptive Biotechnologies Makes Progress Toward T-Cell Assay for Inflammatory Bowel Disease
Premium

Mar 1, 2022

Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year

Feb 16, 2022

Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses
Premium

Feb 15, 2022

Adaptive Biotechnologies Revenues Rise 26 Percent in Q4, 57 Percent in 2021

Jan 11, 2022

JPM Healthcare Conference Day 1: Seer, Twist, 10x, Guardant, Natera, Bruker, Adaptive, Qiagen, Sema4

Jan 10, 2022

Akoya, Olink, NanoString, Adaptive Bio, Sema4, Oxford Nanopore Report Preliminary Financial Results

Jan 4, 2022

Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021

Nov 5, 2021

Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test
Premium

Nov 3, 2021

Adaptive Biotechnologies Q3 Revenues Rise 50 Percent

Oct 1, 2021

New Products Posted to GenomeWeb: Adaptive Biotechnologies, Amazon, Thermo Fisher, More

Aug 13, 2021

People in the News: New Appointments at BD, Adaptive Biotechnologies, ChromaCode, More

Aug 4, 2021

Adaptive Biotechnologies Q2 Revenues Jump 83 Percent

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.